ReportsnReports.com: Bard Medical Device Company Intelligence Report
Espicom Limited's "Bard Medical Device Company Intelligence Report" is now available at ReportsnReports.
- Dallas, TX (1888PressRelease) August 31, 2011 - Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.
Headquartered in Murray Hill, New Jersey, US, C.R. Bard (Bard) develops and manufactures medical, surgical, diagnostic and patient care devices. The company sells its products to hospitals, individual healthcare professionals, extended care health facilities and alternate site facilities in the US and in more than 100 other countries, principally in Europe and Japan. In general, Bard's products are intended to be used once and then discarded or implanted either temporarily or permanently.
Bard medical device report serves the healthcare industry through five divisions - Bard Access Systems Inc, Bard Electrophysiology Division, Bard Medical Division, Bard Peripheral Vascular Inc (including Bard Biopsy Systems) and Davol Inc - and four major product group categories - vascular, urology, oncology and surgical specialties. The company also has a product group of 'Other Products'.
Vascular - Bard's vascular products are produced by Bard Electrophysiology and Bard Peripheral Vascular. The company's vascular products cover a wide range of minimally-invasive devices for the treatment of peripheral vascular disease (PVD) and heart arrhythmias. These products include: percutaneous transluminal angioplasty (PTA) catheters, chronic total occlusions (CTO) catheters, guidewires, introducers and accessories; peripheral vascular stents and stent grafts, vena cava filters and biopsy devices; electrophysiology products, including electrophysiology laboratory systems and diagnostic, therapeutic and temporary pacing electrode catheters; and fabrics, meshes and implantable vascular grafts.
Bard led the industry with the first angioplasty balloon catheter in 1980, giving cardiologists a safer and less costly alternative to open-heart procedures.
The January 2008 acquisition of the LifeStent range of stents from Edwards Lifesciences provided Bard with one of the broadest product offerings for peripheral vascular stenting.
Browse All Medical Device Research Reports -
http://www.reportsnreports.com/market-research/medical-devices/
The acquisition of Y-Med in November 2009 provided Bard with access to the VascuTrak catheter range.
More recently, the acquisition of FlowCardia in April 2010 expanded Bard's portfolio of CTO endovascular products.
Urology - Bard claims to be the worldwide market leader in urological diagnostic and interventional products with a focus on urological drainage, continence and prostate disease management. Through its Bard Medical Division, the company has expanded its urology business to products in the areas of infection control, continence management, prostate management and catheter stabilisation.
Buy Now: http://www.reportsnreports.com/reports/53330-bard-medical-device-company-intelligence-report.html
About Us:
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: +1-888-989-8004
E-mail: sales ( @ ) reportsandreports dot com
http://www.reportsnreports.com
Visit our Market Research Blog
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam